Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country

Pediatric Infectious Disease Journal

Volumn 17, Issue 4, 1998, Pages 287-293

  Levine, Myron M ^a,e   Lagos, Rosanna ^a   Levine, Orin S ^b   Heitmann, Ingrid ^b   Enriquez, Nancy ^c   Eugenia, Maria ^c   Alvarez, Ana Maria ^d   Mayorga, Clara ^d   Reyes, Alejandra ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b HOSPITAL ROBERTO DEL RÍO   (Chile)

^c INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

Cellulitis; Chile; Empyema; Epidemiology; Meningitis; Peritonitis; Pneumococcal disease; Pneumonia; Septic arthritis; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM ISOLATION; CHILD; CHILE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MENINGITIS; PRIORITY JOURNAL; SERODIAGNOSIS; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

AGE FACTORS; CHILD, PRESCHOOL; CHILE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; URBAN POPULATION;

EID: 0031978092     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199804000-00005     Document Type: Article

References (48)

1. Kayhty H, Ahman H, Ronnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.
2. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent pneumococcal conjugate the pneumococca vaccine. J Infect Dis 1996;174:1271-8.
3. Mastro TD, Ghafoor A, Nomani NK, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 1991;l:156-9.
4. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978;299:735-40.
5. Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
6. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
7. Levine MM, Levine OS. Influence of disease burden, public perception, and other factors on new vaccine development, implementation and continued use. Lancet 1997;350:1386-92.
8. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J 1989;8:S11-14.
9. Sloyer JL Jr., Howie VM, Ploussard JH, Ammann AJ, Austrian R, Johnston RB Jr. Immune response to acute otitis media in children: I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect Immun 1974;9:1028-32.
10. Austrian R, Howie VM, Ploussard JH. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J 1977;141: 104-11.
11. Austrian R. Epidemiology of pneumococcal capsular types causing pédiatrie infections. Pediatr Infect Dis J 1989;8: S21-2.
12. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-52.
13. Chretien J, Holland W, Macklem P, Murray P, Woolock A. Acute respiratory infections in children: a global publichealth problem. N Engl J Med 1984;310:982-4.
14. Editorial. Acute respiratory infections in under-fives: 15 million deaths a year. Lancet 1985;11:699-701.
15. Monto AS. Acute respiratory infections in children of developing countries: challenge of the 1990s. Rev Infect Dis 1989; 11:498-505.
16. O'Dempsey TJ, MeArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 1996;15:431-7.
17. Torzillo PJ, Hanna JN, Morey F, Gratten M, Dixon J, Erlich J. Invasive pneumococcal disease in central Australia. Med J Aust 1995;162:182-6.
18. Dagan R, Englehard D, Piccard E, Israeli Peiatric Bacteremia and Meningitis Group. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992;268: 3328-32.
19. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992;268:3323-7.
20. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996;174:752-9.
21. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985;7:133-42.
22. Mufson MA, Oley G, Hughey D. Pneumococcal disease in a medium-sized community in the United States. JAMA 1982; 248:1486-9.
23. Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992;152:2277-82.
24. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: ethnic differences and opportunities for prevention. J Infect Dis 1994;170:368-76.
25. UNICEF. The state of the world's children. Oxford, UK: Oxford University Press, 1996:85.
26. Monckeberg F. Campaign against child undernutrition in Chile, 1952-1977. Rev Med Chil 1977;105:687-95.
27. Donoso G, Monckeberg F. Infantile denutrition: I. General considerations and epidemiology. Rev Chil Pediatr 1965;36: 301-11.
28. DiFabio JL, Homma A, DeQuadros C. Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae. Microbial Drug Resist 1997;3:131-3.
29. Klein DL, Ellis RW. Conjugate vaccines against Streptococcus pneumoniae. chap 36. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, eds. New generation vaccines. 2nd ed. New York: Dekker, 1997:503-26.
30. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina. Arch Intern Med 1990; 150:1401-5.
31. Voss L, Lennon D, Okesene-Gafa K, Aermatugna S, Martin D. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr Infect Dis J 1994;13:873-8.
32. Teele DW, Pelton SI, Grant MJA, et al. Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr 1975;87:227-30.
33. Long SS. Antibiotic therapy in febrile children: "best-laid schemes." J Pediatr 1994;124:585-8.
34. Jaffe DM, Tanz RR, Davis AT, Henretig F, Fleisher G. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med 1987;317:1175-80.
35. Vergara R, Urrejola P, Abargo K, et al. Bacteremia oculta en nifios de 2 a 36 meses de edad [Abstract]. Presented at the Annual Meeting of the Sociedad Chilena de Pediatria, Concepcion, Chile, November 21 to 24, 1990, Summary Booklet published by the Chilean Society of Pediatrics, p. 82.
36. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990;162:1316-23.
37. Ghafoor A, Nomani NK, Ishaq Z, et al. Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan. Rev Infect Dis 1990;12:S907-14.
38. Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber SR. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995;346:1252-7.
39. Sniadack DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies. Pediatr Infect Dis J 1995;14:503-10.
40. Dowling JN, Sheehe PR, Feldman HA. Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study. J Infect Dis 1971;124:9-17.
41. Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA, Denny FW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 1975;87:1087-93.
42. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-32.
43. Broome CV, Facklam RR, Alien JR, Fraser DW, Austrian R. Epidemiology of pneumococcal serotypes in the United States, 1978-1979. J Infect Dis 1980;141:119-23.
44. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis 1994;169:212-13.
45. Greenwood BM, Hassan-King M, Macfarlane JT, et al. Pneumococcal serotypes in west Africa. Lancet 1980;1:360.
46. De Francisco A, Hall AJ, Schellenberg JR, Greenwood AM, Greenwood BM. The pattern of infant and childhood mortality in Upper River Division, The Gambia. Ann Trop Paediatr 1993;13:345-52.
47. Fischer GW, Ottolini MG, Mond JJ. Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol 1997;24:231-49.
48. Mulholland K, Suara RO, Siber G, et al. Maternal immunization with Haemophilus influenzas type b polysaccharidetetanus protein conjugate vaccine in The Gambia. JAMA 1996;275:1182-8.